Journal Club 2025

journal club image Spacer Image

Next HOPA Journal Club

Thursday, February 13, 2025 at 12 p.m. Central Time

Listen to critical evaluations of hematology/oncology pharmacy publications presented by PGY2 Oncology Residents.

Click here to register for February's Journal Club!

Spacer Image

Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): A multicentre, single-arm, phase 2b study

Megan Mills headshot

Megan Mills, PharmD, PGY-2 Oncology Pharmacy Resident

Froedtert and the Medical College of Wisconsin, Milwaukee, WI

Article:

Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): A multicentre, single-arm, phase 2b study

Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: A randomized phase 3 trial

Jihan Eli headshot

Jihan Eli, PharmD, PGY-2 Oncology Pharmacy Resident

University of MN - Fairview, Minneapolis, MN

Article:

Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: A randomized phase 3 trial

Spacer Image

Reserve your spot for February's Journal Club!

Want to be a Journal Club Presenter?

The next call for the January-June 2025 session speakers is currently closed. Stay tuned for future opportunities.